Medeor Therapeutics Receives FDA Clearance of IND Application and Special Protocol Assessment for Pivotal Clinical Study of MDR-101
April 28, 2017 07:30 ET | Medeor Therapeutics
Personalized cellular immunotherapy designed to prevent transplant kidney rejection and eliminate the need for chronic anti-rejection drugs Single Phase 3 study will evaluate functional immune...